The active ingredient in Genfulin® is molgramostim (recombinant human granulocyte/ macrophage colony-stimulating factor, rhGM-CSF [rDNA origin]) produced by GenScis patented E.coli secretion technology. Clinical trials show its efficacy in actively accelerating wound healing, increasing wound tearing-resistance, and reducing, even avoiding, scar proliferation in burn patients. Genfulin® is used in the treatment of deep II-degree burns and wound healing.
Strengths: * 100 μg rhGM-CSF/10g/tube
|